Columnist Allyx Formalejo says that she and her husband, Jared, are managing hemophilia in a less impulsive and more ...

Columnist G Shellye Horowitz applied the advocacy she learned on her hemophilia journey to get a new rare diagnosis. She ...

Driving through the orchard, watching the leaves shimmer and fall, I came to understand something that brought me peace. Much of my life as a mother, advocate, and chaplain has been shaped by routines ...

Data from a primate study suggested MGX-001 has potential as a hemophilia A treatment, moving the drug closer to clinical ...

Hemlibra (emicizumab-kxwh) safely supports joint health in children with hemophilia A without inhibitors through three years ...

Every woman with a bleeding disorder knows about doubt, writes columnist. But it's important to keep speaking out.

Columnist Jennifer Lynne talks to Connie Montgomery, who has factor VII deficiency, about her advocacy for women with bleeding disorders.

Jennifer Lynne is an entrepreneur specializing in digital marketing, a self-professed computer nerd, and a nationally competitive Scrabble player. Jennifer has strong ties to the bleeding disorder ...

Hemophilia C is a rare bleeding disorder caused by a deficiency of factor XI, a protein needed for blood to clot. Symptoms can vary, with some people experiencing only mild bleeding. Unlike other ...

Many women with hemophilia grew up being taught to downplay their symptoms, writes columnist. That is the wrong approach.

There is no cure for hemophilia, but there are treatments available that can help manage the disease and maintain quality of life. In addition to existing approved treatments, several experimental ...

Novo Nordisk has submitted an application to the U.S. Food and Drug Administration seeking approval to market Mim8 (denecimig), an injection therapy for preventing bleeds in people with hemophilia A ...